• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (GFO) LUTONIX 035 DRUG COATED BALLOON PTA CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (GFO) LUTONIX 035 DRUG COATED BALLOON PTA CATHETER Back to Search Results
Model Number 9004
Device Problems Kinked (1339); Material Rupture (1546); Scratched Material (3020)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 07/05/2017
Event Type  malfunction  
Manufacturer Narrative
Analysis/device evaluation: upon receipt of the sample, visual examination was performed over the entire length of the catheter, which revealed a kink in both the balloon and inner shaft at the proximal end of the catheter.Functional testing was performed by inflating the balloon which revealed a material rupture in the middle of the balloon.A lot history review revealed this is the only complaint from this lot associated with an allegation of balloon rupture.A device history record (dhr) was reviewed for this device.A review of the manufacturing record indicates the lot was manufactured to specification.Conclusion: the returned sample is undergoing evaluation which has not yet been completed.Upon completion of the investigation, a supplement report will be submitted with all relevant information the information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event Description
It was reported a lutonix percutaneous transluminal drug coated balloon (dcb) dilatation catheter allegedly ruptured prior to reaching 6 atmospheres(atms) at the target lesion.The health care professional (hcp) used an ipselateral approach to treat the superficial femoral artery (sfa).The hcp reportedly predilated the target lesion.The vessel morphology and lesion were not calcified or tortuous.Reportedly, no stents had previously been placed in the vessel.The hcp reached the target lesion and attempted the first inflation of the balloon.Reportedly, prior to reaching 6 atms, the balloon allegedly ruptured.The hcp removed the ruptured balloon in its entirety and used another lutonix dcb to complete the procedure.In the hcp's opinion, the anatomy and or vessel morphology did not contribute to the balloon rupture.The lutonix dcb was returned for evaluation.No adverse patient outcomes were reported.
 
Manufacturer Narrative
Other relevant history was changed from "unknown" to "although requested, patient demographics were unavailable." (b)(4).Analysis/device evaluation was updated with the following: "which revealed a kink in both the balloon and inner shaft approximately 55mm from the proximal balloon bond.The distal end of the balloon was wrinkled.Functional testing was performed by applying negative pressure which could not be maintained.The balloon was attempted to be inflated to 8 atmospheres (atms), but pressure was unable to be maintained due to solution coming from a material rupture, identified in the middle of the balloon.The material rupture was approximately 76mm from the proximal balloon bond.Under microscopic evaluation, a small hole was detected within a scratch, found under a fold of the balloon." analysis/device evaluation: upon receipt of the sample, visual examination was performed over the entire length of the catheter, which revealed a kink in both the balloon and inner shaft approximately 55mm from the proximal balloon bond.The distal end of the balloon was wrinkled.Functional testing was performed by applying negative pressure which could not be maintained.The balloon was attempted to be inflated to 8 atmospheres (atms), but pressure was unable to be maintained due to solution coming from a material rupture, identified in the middle of the balloon.The material rupture was approximately 76mm from the proximal balloon bond.Under microscopic evaluation, a small hole was detected within a scratch, found under a fold of the balloon.A lot history review revealed this is the only complaint from this lot associated with an allegation of balloon rupture.A device history record (dhr) was reviewed for this device.A review of the manufacturing record indicates the lot was manufactured to specification.Conclusion: returned product analysis confirmed the material rupture to be a small hole within a scratch found under a fold of the balloon.There was nothing found to indicate there was a manufacturing related cause for this event.A definitive root cause could not be determined based on the information provided.It is unknown if the patient and/or procedural issues contributed to the reported event.If additional information becomes available, a supplement report will be submitted with all relevant information.
 
Event Description
It was reported a lutonix percutaneous transluminal drug coated balloon (dcb) dilatation catheter allegedly ruptured prior to reaching 6 atmospheres(atms) at the target lesion.The health care professional (hcp) used an ipslateral approach to treat the superficial femoral artery (sfa).The hcp reportedly predilated the target lesion.The vessel morphology and lesion were not calcified or tortuous.Reportedly, no stents had previously been placed in the vessel.The hcp reached the target lesion and attempted the first inflation of the balloon.Reportedly, prior to reaching 6 atms, the balloon allegedly ruptured.The hcp removed the ruptured balloon in its entirety and used another lutonix dcb to complete the procedure.In the hcp's opinion, the anatomy and/or vessel morphology did not contribute to the balloon rupture.The lutonix dcb was returned for evaluation.No adverse patient outcomes were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LUTONIX 035 DRUG COATED BALLOON PTA CATHETER
Type of Device
DRUG COATED BALLOON PTA CATHETER
Manufacturer (Section D)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
john risse
9409 science center dr
new hope, MN 55428
7634632917
MDR Report Key6770286
MDR Text Key81927293
Report Number3006513822-2017-00150
Device Sequence Number1
Product Code ONU
UDI-Device Identifier00801741088766
UDI-Public(01)00801741088766
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
P130024
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,user f
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 09/22/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/31/2018
Device Model Number9004
Device Catalogue Number9080413600150
Device Lot NumberGFAN1538
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/02/2017
Is the Reporter a Health Professional? No
Event Location Hospital
Initial Date Manufacturer Received Not provided
Initial Date FDA Received08/07/2017
Supplement Dates Manufacturer Received09/11/2017
Supplement Dates FDA Received09/22/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/15/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-